Zenas Biopharma, INC. (ZBIO) — 10-K Filings
All 10-K filings from Zenas Biopharma, INC.. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
Zenas BioPharma Files 2024 10-K, Reports $81M R&D Spend
— Mar 11, 2025 Risk: medium
Zenas BioPharma, Inc. filed its 2024 10-K on March 11, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, inco
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX